1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 2. 
MR Imaging characteristics of patients with pathologic rRCCs
PatientMax Dimension (mm)Bone Marrow EnhancementT2 SignalT2 Dark NoduleT1 Hyperintense SignalLocation
111.5FocalHyperintenseNoNoMidline
214.0FocalHypointenseNoYesMidline
310.8DiffuseHeterogeneousNoNoMidline
410.8DiffuseHyperintenseYesYesOff-midline
511.1DiffuseHyperintenseYesNoMidline
68.2FocalHeterogeneousNoNoReplaces entire pituitary
712.2DiffuseHyperintenseYesNoReplaces entire pituitary
  • Note:—Max indicates maximum.